CPG Working group for Prostate cancer Treatment

Antonio Antón Torres, Specialist in Medical Oncology,
“Miguel Servet” University Hospital, Zaragoza.
Ángel Borque Fernando, Specialist in Urology,
“Miguel Servet” University Hospital, Zaragoza.
Verónica Calderero Aragón, Specialist in Medical Oncology,
“Miguel Servet” University Hospital, Zaragoza.
Ricardo Escó Barón, Specialist in Radiotherapeutic Oncology,
“Lozano Blesa” University Clinical Hospital, Zaragoza.
Elvira Elena García Álvarez, Specialist in Preventive Medicine and Public Health,
Aragon Institute of Health Sciences, Zaragoza.
Mª Jesús Gil Sanz, Specialist in Urology,
“Miguel Servet” University Hospital, Zaragoza.
Mercedes Martín Valenciano, Nurse,
“Miguel Servet” University Hospital, Zaragoza.
Agustina Méndez Villalón, Specialist in Radiotherapeutic Oncology,
“Miguel Servet” University Hospital. Zaragoza.
Luis Plaza Mas, Specialist in Pathological Anatomy,
“Miguel Servet” University Hospital, Zaragoza.
Luis Ángel Rioja Sanz, Specialist in Urology,
“Miguel Servet” University Hospital, Zaragoza.
Alberto Sáenz Cusí, Specialist in Medical Oncology,
“Lozano Blesa” University Clinical Hospital, Zaragoza.
Martín Tejedor Gutiérrez, Specialist in Radiotherapeutic Oncology,
“Miguel Servet” University Hospital, Zaragoza.
Carmen Velilla Millán, Specialist in Radiotherapeutic Oncology,
“Lozano Blesa” University Clinical Hospital, Zaragoza.

Coordination

Clinical Area
Luis Ángel Rioja Sanz, Specialist in Urology,
“Miguel Servet” University Hospital, Zaragoza.

Methodological Area
Juan Ignacio Martín Sánchez, Specialist in Preventive Medicine and Public Health,
Aragon Institute of Health Sciences, Zaragoza.
José Mª Mengual Gil, Specialist in Paediatrics,
Aragon Institute of Health Sciences, Zaragoza.

Collaborators

Documentalist
Montserrat Salas Valero, Aragon Institute of Health Sciences, Zaragoza.

Other collaborators
Silvia Castán Ruiz, Specialist in Preventive Medicine and Public Health,
Aragon Institute of Health Sciences, Zaragoza.
Raquel Espílez Ortiz, Specialist in Urology,
“San Jorge” Hospital, Huesca.
Alberto Fantova Alonso, Urology Resident Intern,
“Miguel Servet” University Hospital, Zaragoza.
Ana Marco Valdenebro, Specialist in Urology,
“Miguel Servet” University Hospital, Zaragoza.
Mª Pilar Medrano Llorente, Urology Resident Intern,
“Royo Villanova” Hospital, Zaragoza.

Expert Collaborators

Joaquín Carballido, Specialist in Urology,
“Puerta de Hierro” University Hospital, Madrid
Antoni Gelabert Mas, Specialist in Urology,
Hospital del Mar, Barcelona.
Pedro José Prada Gómez, Specialist in Radiotherapeutic Oncology,
Asturias Central Hospital University, Oviedo.
Isabel Rodríguez Rodríguez, Specialist in Radiotherapeutic Oncology,
“La Paz” University Hospital, Madrid.
Carlos Tello Royloa, Specialist in Urology,
“Vega Baja” Hospital, Orihuela (Alicante).

External Review

Joaquim Bellmunt Molins, Specialist in Medical Oncology,
Hospital del Mar, Barcelona.
Francisco Gómez Veiga, Specialist in Urology,
Juan Canalejo Hospital Complex, La Coruña.
José López Torrecilla, Specialist in Radiotherapeutic Oncology,
University General Hospital, Valencia.
Juan Morote Robles, Specialist in Urology,
“Vall d’Hebron” Hospital, Barcelona.
Alfredo Rodríguez Antolín, Specialist in Urology,
“12 October” University Hospital, Madrid.
Milagros Sagüillo Antolín, Nurse, Móstoles Hospital, Madrid.
Anna Quintanilla Sanz, Nurse, Ponent Clinic, Lleida.

Collaborating organisations

Spanish Association of Urology
Spanish Society of Radiotherapeutic Oncology
Spanish Society of Medical Oncology
Spanish Association of Nursing in Urology
Members of these organisations have participated in the authorship, expert collaboration and external review of the CPG.

Declaration of interest: All members of the Working Group, as well as persons who have participated in the expert collaboration and the external review, have declared their interests, presented in Appendix 5.